NO992472D0 - FremgangsmÕte for Õ diagnostisere metabolske bensykdommer - Google Patents

FremgangsmÕte for Õ diagnostisere metabolske bensykdommer

Info

Publication number
NO992472D0
NO992472D0 NO992472A NO992472A NO992472D0 NO 992472 D0 NO992472 D0 NO 992472D0 NO 992472 A NO992472 A NO 992472A NO 992472 A NO992472 A NO 992472A NO 992472 D0 NO992472 D0 NO 992472D0
Authority
NO
Norway
Prior art keywords
ocif
metabolic bone
diagnosing metabolic
antibodies recognizing
arthrosis
Prior art date
Application number
NO992472A
Other languages
English (en)
Other versions
NO992472L (no
Inventor
Kazuki Yano
Fumie Kobayashi
Masaaki Goto
Naohiro Washida
Eisuke Tsuda
Kanji Higashio
Yoshiji Yamada
Original Assignee
Snow Brand Milk Products Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Snow Brand Milk Products Co Ltd filed Critical Snow Brand Milk Products Co Ltd
Publication of NO992472L publication Critical patent/NO992472L/no
Publication of NO992472D0 publication Critical patent/NO992472D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/108—Osteoporosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809—Fused cells, e.g. hybridoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
NO992472A 1997-09-24 1999-05-21 FremgangsmÕte for Õ diagnostisere metabolske bensykdommer NO992472D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP27647597 1997-09-24
PCT/JP1998/003421 WO1999015691A1 (fr) 1997-09-24 1998-07-31 Procede permettant de diagnostiquer un dysfonctionnement du metabolisme osseux

Publications (2)

Publication Number Publication Date
NO992472L NO992472L (no) 1999-05-21
NO992472D0 true NO992472D0 (no) 1999-05-21

Family

ID=17569976

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992472A NO992472D0 (no) 1997-09-24 1999-05-21 FremgangsmÕte for Õ diagnostisere metabolske bensykdommer

Country Status (16)

Country Link
US (2) US6693175B2 (no)
EP (1) EP0974671B1 (no)
JP (1) JP4268684B2 (no)
KR (1) KR100547395B1 (no)
CN (1) CN1183159C (no)
AT (1) ATE328281T1 (no)
AU (1) AU739304B2 (no)
CA (1) CA2269114A1 (no)
DE (1) DE69834719D1 (no)
HU (1) HUP0002062A3 (no)
IL (1) IL129535A (no)
NO (1) NO992472D0 (no)
NZ (1) NZ335759A (no)
RU (1) RU2203497C2 (no)
WO (1) WO1999015691A1 (no)
ZA (1) ZA986974B (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL117175A (en) * 1995-02-20 2005-11-20 Sankyo Co Osteoclastogenesis inhibitory factor protein
NZ511506A (en) 1998-10-28 2004-02-27 Sankyo Co Remedies for bone metabolic errors comprising OCIF
JP3709332B2 (ja) * 2000-09-14 2005-10-26 株式会社エーシーバイオテクノロジーズ 骨粗鬆症の診断および／または骨粗鬆症骨折リスクの予測の方法
WO2002062990A1 (fr) * 2001-02-07 2002-08-15 Sankyo Company, Limited Anticorps et utilisation de cet anticorps
WO2002079256A1 (fr) * 2001-03-26 2002-10-10 Sankyo Company, Limited Anticorps et son utilisation
PT1757619E (pt) * 2001-04-03 2010-03-25 Nestle Sa Osteoprotegerina no leite
EP1270015A3 (en) * 2001-06-29 2004-02-25 Sankyo Company Limited A complex comprising OCIF and Polysaccharide
PA8568001A1 (es) * 2002-03-01 2003-11-12 Sankyo Co Composicion farmaceutica
US7279451B2 (en) 2002-10-25 2007-10-09 Honeywell International Inc. Compositions containing fluorine substituted olefins
AU2002343870A1 (en) * 2002-11-07 2004-06-07 Kumamoto Technology And Industry Foundation Transgenic mammal carrying ganp and utilization thereof
KR100545064B1 (ko) * 2003-05-26 2006-01-24 김현기 인간 원암단백질에 특이적인 항체를 포함하는 간경변증진단 키트
KR101414064B1 (ko) * 2006-05-17 2014-07-01 더 리서치 파운데이션 포 더 스테이트 유니버시티 오브 뉴욕 세포 배양액 중의 세포의 운명에 영향을 미치는 방법
US10029089B2 (en) 2010-10-15 2018-07-24 Research Foundation For The State University Of New York, The Compositions and methods for enhancing the biological response to chemical agents and physical stimuli
RU2524616C1 (ru) * 2013-01-21 2014-07-27 Государственное бюджетное образовательное учреждение высшего профессионального образования "Владивостокский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ГОУ ВПО ВГМУ Минздрава России) Способ диагностики ранней стадии ревматоидного артрита
GB201302257D0 (en) 2013-02-08 2013-03-27 Nobel Biocare Services Ag Method for measuring bone loss rate
CN106405064B (zh) * 2016-08-30 2018-10-26 嘉兴行健生物科技有限公司 一种40岁以上女性骨转换率的评估方法
CN109540818A (zh) * 2018-12-21 2019-03-29 云南农业大学 一种基于钙、磷血液生化标记选育武定鸡的方法
CN113621060B (zh) * 2020-05-07 2023-07-04 浙江瑞硕生物技术有限公司 一种opg抗体对及其应用

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
US4444879A (en) * 1981-01-29 1984-04-24 Science Research Center, Inc. Immunoassay with article having support film and immunological counterpart of analyte
AU645742B2 (en) * 1988-10-24 1994-01-27 Bruce Caterson Methods of and compositions for diagnosing, monitoring and treating the early stages of osteoarthritis
AU651421B2 (en) 1990-11-30 1994-07-21 Celtrix Pharmaceuticals, Inc. Use of a bone morphogenetic protein in synergistic combination with TGF-beta for bone repair
US5118667A (en) 1991-05-03 1992-06-02 Celtrix Pharmaceuticals, Inc. Bone growth factors and inhibitors of bone resorption for promoting bone formation
CA2068389A1 (en) 1991-05-13 1992-11-14 Masahiko Sato Method for inhibiting bone resorption
MX9204303A (es) 1991-07-23 1993-11-01 Rhone Poulenc Rorer Int Factor regulador del crecimiento de osteoclasto.
US5366859A (en) * 1991-10-31 1994-11-22 Mitsubishi Petrochemical Co., Ltd. Radioimmunoassay method
US5447851B1 (en) 1992-04-02 1999-07-06 Univ Texas System Board Of Dna encoding a chimeric polypeptide comprising the extracellular domain of tnf receptor fused to igg vectors and host cells
US5427954A (en) * 1992-04-29 1995-06-27 Shriner's Hospitals For Crippled Children Compositions and methods for detection and treatment of human osteoarthritis
US5578569A (en) 1993-03-12 1996-11-26 Tam; Cherk S. Method of increasing bone growth
JPH09502614A (ja) 1993-09-14 1997-03-18 メルク エンド カンパニー インコーポレーテッド 新規ヒト蛋白質チロシンホスファターゼをコードするｃＤＮＡ
US6046033A (en) * 1994-06-27 2000-04-04 Snow Brand Milk Products Co., Ltd. Basic osteoblast growth factor II (bOGF-II)
EP0727211A1 (en) 1995-02-10 1996-08-21 Smithkline Beecham Corporation Use of src SH2 specific compounds to treat a bone resorption disease
IL117175A (en) * 1995-02-20 2005-11-20 Sankyo Co Osteoclastogenesis inhibitory factor protein
WO1996028546A1 (en) 1995-03-15 1996-09-19 Human Genome Sciences, Inc. Human tumor necrosis factor receptor
AU6090896A (en) * 1995-06-07 1997-01-15 Osteosa Inc. Osteoclast growth regulatory factor
AU5985996A (en) 1995-06-07 1997-01-15 Osteosa Inc. Osteoclast growth regulatory factor
US6613544B1 (en) * 1995-12-22 2003-09-02 Amgen Inc. Osteoprotegerin
US6369027B1 (en) * 1995-12-22 2002-04-09 Amgen Inc. Osteoprotegerin
JPH1057071A (ja) 1996-08-19 1998-03-03 Snow Brand Milk Prod Co Ltd 新規ｄｎａ及びそれを用いた蛋白質の製造方法
US5830850A (en) * 1996-08-28 1998-11-03 Mount Sinai School Of Medicine Of The City Of New York Methods for the treatment of bone resorption disorders, including osteoporosis
AU5901598A (en) 1996-12-20 1998-07-17 Board Of Regents, The University Of Texas System Compositions and methods of use for osteoclast inhibitory factors
DE69738841D1 (de) 1996-12-23 2008-08-28 Immunex Corp Ligand für rezeptor aktivator of nf-kappa b, ligand ist mitglied der tnf superfamilie
US5843678A (en) 1997-04-16 1998-12-01 Amgen Inc. Osteoprotegerin binding proteins

Also Published As

Publication number Publication date
NO992472L (no) 1999-05-21
HUP0002062A3 (en) 2002-09-30
ATE328281T1 (de) 2006-06-15
KR20000068916A (ko) 2000-11-25
US20020004207A1 (en) 2002-01-10
IL129535A0 (en) 2000-02-29
HUP0002062A2 (hu) 2000-10-28
US6693175B2 (en) 2004-02-17
EP0974671A8 (en) 2002-07-03
IL129535A (en) 2003-07-06
EP0974671B1 (en) 2006-05-31
US6998242B2 (en) 2006-02-14
NZ335759A (en) 2002-02-01
EP0974671A4 (en) 2004-10-22
ZA986974B (en) 1999-02-04
RU2203497C2 (ru) 2003-04-27
CA2269114A1 (en) 1999-03-24
KR100547395B1 (ko) 2006-02-01
JP4268684B2 (ja) 2009-05-27
DE69834719D1 (de) 2006-07-06
AU739304B2 (en) 2001-10-11
AU8461798A (en) 1999-04-12
CN1239515A (zh) 1999-12-22
US20040033533A1 (en) 2004-02-19
WO1999015691A1 (fr) 1999-04-01
CN1183159C (zh) 2005-01-05
EP0974671A1 (en) 2000-01-26

Similar Documents

Publication Publication Date Title
NO992472L (no) FremgangsmÕte for Õ diagnostisere metabolske bensykdommer
DE59008278D1 (de) Spezifische Antikörper gegen Troponin T, ihre Herstellung und Verwendung in einem Reagenz zur Bestimmung von Herzmuskelnekrosen.
DK104093D0 (da) Fremgangsmaade til bestemmelse af collagen-fragmenter i legemsvaesker, test-kit og midler til udoevelse af fremgangsmaaden og anvendelse af fremgangsmaaden til diagnosticering af lidelser associeret til collagen-metabolismen
DE69126248T2 (de) Immunchromatographischer assay und verfahren zur nutzung desselben
DE394296T1 (de) Urintest zur messung von knochenresorption.
ATE120549T1 (de) Verfahren zur bestimmung von hiv-antikörpern.
RU99113447A (ru) Способ диагностики метаболических костных заболеваний
WO2003046140A3 (en) Immunoassay and kit for an early and simulataneous detection of biochemical markers in a patient's sample
ATE142646T1 (de) Verfahren zur immunologischen bestimmung des carboxyterminalen peptids von typ-i-prokollagen
ES2072423T3 (es) Anticuerpo monoclonal e inmunoensayo para el factor beta xiia de coagulacion de la sangre.
EP0245052A3 (en) Detection of inflammation and novel antibodies therefor
EP1245957A3 (en) Method of measuring ceruloplasmin concentration with enzyme-linked immunosorbent assay or dissociation-enhanced time-resolved fluoroimmunoassay in a blood spot, and Wilson's disease screening kit and method of diagnosing Wilson's disease
ES2094784T3 (es) Procedimiento para la determinacion de un analito.
GB9507985D0 (en) Antibody to aminoterminal propeptide to type 1 procollagen and assay method using it
FR2700011B1 (fr) Détection de la mucoviscidose ou d'une mutation du gêne CFTR au moyen d'un dosage de la PAP.
DE69026875T2 (de) Immunobestimmung von menschlichem osteocalcin, reagenz und satz dafür
ATE180894T1 (de) Verwendung von polyklonalen humanen anti-htg- autoantikörpern als reagenz für die klinische diagnostik von schilddrüsen-autoimmunerkrankungen sowie reagenziensatz für eine bestimmung von anti-htg-autoantikörpern in patientenseren
ATE286596T1 (de) Chemische modifikation von antikörpern und antigenen
ITMI930477A1 (it) Saggio per la determinazione di un antigene/anticorpo in un campione di prova e corredo per l'attuazione del saggio
WO1990008956A1 (fr) Detection d'activateur de facteur tissulaire humain
RU97120690A (ru) Способ определения m.leprae у больных с регрессом заболевания
ATE302949T1 (de) Knorpelresorptionsassays
DE69637466D1 (de) Verfahren zur prüfung von antigenen, die mit durch mentalen stress bedingten erkrankungen assoziiert sind
RU94042702A (ru) Способ прогнозирования прогрессирования миопии у детей
RU97106519A (ru) Способ определения метадона в биологических жидкостях

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application